Oncology is IQVIA Biotech’s largest area of focus with expertise across adoptive cell therapy, biologics, and small molecules. Our extensive immuno-oncology expertise spans multiple treatment modalities and numerous indications across hematologic malignancies and solid tumors. Adoptive cell therapies, in combination with other IO treatment modalities, are reshaping the oncology treatment landscape, and we want to be your partner in your next breakthrough.

Download this fact sheet to learn more about our immuno-oncology clinical trial expertise.